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Summary
A novel type of infantile nephronophthisis was identified
in an extended Bedouin family from Israel. This disease
has an autosomal recessive mode of inheritance, with
the phenotypic presentation ranging from a Potter-like
syndrome to hyperechogenic kidneys, renal insufficiency,
hypertension, and hyperkalemia. Affected individuals
show rapid deterioration of kidney function, leading to
end-stage renal failure within 3 years. Histopathologic
examination of renal tissue revealed variable findings,
ranging from infantile polycystic kidneys to chronic tub-
ulointerstitial nephritis, fibrosis, and cortical microcysts.
A known familial juvenile nephronophthisis locus on
chromosome 2q13 and autosomal recessive polycystic
kidney disease on chromosome 6p21.1-p12 were ex-
cluded by genetic linkage analysis. A genomewide screen
for linkage was conducted by searching for a locus in-
herited by descent in all affected individuals. Pooled
DNA samples from parents and unaffected siblings and
individual DNA samples from four affected individuals
were used as PCR templates with trinucleotide- and tet-
ranucleotide-repeat polymorphic markers. Using this
approach, we identified linkage to infantile nephron-
ophthisis for markers on chromosome 9q22-31. The dis-
order maps to a 12.9-cM region flanked by markers
D9S280 and GGAT3G09.
Introduction
Several syndromes involving disruption of kidney de-
velopment and function exist (Lundin and Olow 1961;
Isdale et al. 1973; Welling and Grantham 1996). These
disorders are heterogeneous (Medhiob et al. 1994) and
display both autosomal recessive and autosomal domi-
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nant modes of inheritance, with variable age at onset.
Nephronophthisis is characterized by the development
of cysts at the corticomedullary junction, in association
with chronic tubulointerstitial nephritis (Strauss and
Sommers 1967), and is distinguished from other med-
ullary cystic disorders—such as Senior-Loken syndrome
(Loken et al. 1961; Senior 1973) and autosomal reces-
sive polycystic kidney disease (ARPKD; MIM 263200)
(Kaplan et al. 1989; Shaikewitz and Chapman 1993;
Zerres et al. 1994)—in that nephronophthisis has a
purely renal pathophysiology. Juvenile nephronophthisis
(NPH1; MIM 256100) presents late in the first decade
of life. This autosomal recessive disorder has been
mapped to chromosome 2q13 (Antignac et al. 1993),
and recent molecular studies have identified, at this lo-
cus, a gene (NPHP1) that is involved in most cases of
NPH1 (Hildebrandt et al. 1997). Gagnadoux et al.
(1989) described a group of infants who reached end-
stage renal disease (ESRD) before 2 years of age, with
chronic tubulointerstitial nephritis that had pathological
features similar to juvenile nephronophthisis. This dis-
order has been designated “infantile nephronophthisis”
(NPH2).
In the current study, an inbred Bedouin kindred with
multiple cases of NPH2 (fig. 1) was used to search for
a disease locus by genetic linkage analysis. The pattern
of inheritance within the kindred and the presence of
consanguinity indicate an autosomal recessive mode of
inheritance. Because of the inbred nature of the family,
all the affected individuals were assumed to have de-
scended from a common ancestor. A homozygosity map-
ping strategy (Lander and Botstein 1987) was employed
to search for a locus causing infantile nephronophthisis
in this kindred.
Material and Methods
Clinical Evaluation
Medical records of all infantile nephronophthisis pa-
tients receiving treatment at the Pediatric Nephrology
Clinic at the Soroka Medical Center in the past 16 years
were reviewed. All examined patients belonged to the
same kindred (fig. 1) and were products of consanguin-
eous matings. Subjects VII-3, VII-7, and VII-17 came to
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Figure 1 Pedigree of infantile nephronophthisis kindred. Solid symbols denote affected individuals; open symbols denote unaffected
individuals. Genotypes of flanking and linked markers are shown below each symbol. Note that all the affected individuals are homozygous
for the most tightly linked markers (D9S910 and D9S938).
medical attention at the onset of clinical symptoms,
whereas the other affected infants and fetuses were ex-
amined because of a previously diagnosed case in the
family. Disease onset was determined as the first ap-
pearance of symptoms or evidence of renal dysfunction.
Genotyping
DNA was prepared from whole-blood samples by a
standard nonorganic protocol (Miller et al. 1988). DNA
concentrations were determined by spectrophotometric
readings at OD260. Blood samples from unaffected sib-
lings and parents were diluted to 100 ng/ml, and a second
reading was taken to confirm the concentrations. DNA
samples from 11 parents were pooled together and then
diluted to a final concentration of 20 ng/ml. A second
pool was created in the same manner with DNA from
seven unaffected siblings, yielding a final concentration
of 20 ng/ml. DNA samples from affected individualswere
diluted separately to a final concentration of 20 ng/ml.
All of the DNA samples, both pools and individual
samples from the affected individuals, were PCR ampli-
fied with several short tandem-repeat polymorphisms
(STRPs) to verify the quality of amplification and integ-
rity of allele frequencies found in the pooled samples.
STRPs were amplified with 40 ng of DNA in an 8.3-ml
PCR reaction containing 1.25 ml of PCR buffer (100
mM Tris-HCl, pH 8.8, 500 mM KCl, 15 mM MgCl2,
and .01% w/v gelatin); 200 mmol each of dATP, dCTP,
dGTP, and dTTP; 2.5 pmol of each forward and reverse
primer; and 0.25 U Taq polymerase. When possible,
markers were multiplexed. PCR reactions were subject
to the following cycling conditions: 35 cycles of 94C
for 30 s, 55C for 30 s, and 72C for 30 s. PCR products
were electrophoresed on denaturing (7.7 molar urea)
polyacrylamide (6%) gels. The gels were visualized by
silver staining (Bassam et al. 1991). The genetic markers
used in this study were developed by the Cooperative
Human Linkage Center (CHLC). A modified version of
the CHLC STRP screening set, version 6.0, was used in
the genome screen. The screening set was modified by
replacing dinucleotide repeat markers with trinucleotide
and tetranucleotide STRPs.
Statistical Analysis
LOD scores analysis was performed on the Bedouin
family by means of the MENDEL program (Lange et al.
1988), which accommodated the inbreeding loops in the
family. The disease was assumed to be autosomal re-
cessive with complete penetrance. Allele frequencies
were assumed to be equal for each marker.
Results
Clinical Evaluation
Ten affected subjects (seven males and three females)
were the offspring of six Bedouin couples (fig. 1). The
clinical features are summarized in table 1. The mani-
festations of NPH2 range from prenatal fetal oliguria
and oligohydramnion resulting in postnatal respiratory
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Table 1
Clinical Features at Presentation of Infantile Nephronophthisis Patients
Patient
Age at Onset
(mo) Echogenic Kidneys HTN
Hgb
(g/dl)
GFR
(ml per min/1.732 m2)
Serum K
(mmol per liter)
VII-1 30 * ) 9.2 41 5.3
VII-3 30 * ) 8.7 48 5.3
VII-4 8   6.4 20 6.8
VII-7 11  ) 8.2 30 5.8
VII-10 3 NA  7.0 22 7.7
VII-12 3 * NA 8.9 41 7.0
VII-13 2 NA ) 9.9 36 6.5
VII-17 3   6.9 22 5.6
VII-18 0  NA NA NA NA
VII-20 3 * ) 9.2 61 6.1
Mean 7.810.4 8/8 3/8 8.31.2 3613 6.2.8
NOTE.—Hypertension (HTN), hemoglobin value (Hgb), and glomerular filtration rate (GFR) were calculated by
the Schwartz formula. Asterisks (*) indicate that echogenic kidneys preceded clinical renal failure. Moderately
enlarged kidneys are indicated by a plus sign (); massively enlarged kidneys are indicated by two plus signs ().
Prepartum onset is indicated by a zero (0) in the age at onset column; NA indicates that data were not available.
failure and death (patient VII-18) to postnatal onset of
disease at X30 mo of age. None of the postnatally di-
agnosed patients had a history of either oligohydramnios
or neonatal respiratory symptoms. Patients VII-1, VII-
3, VII-12, and VI-20 were identified early because of
family history. Prospective serial renal sonograms per-
formed on these four patients revealed hyperechogenic
kidneys prior to the development of symptoms and ab-
normal laboratory findings. Renal sonography of all pa-
tients revealed enlarged and echogenic kidneys that
lacked corticomedullary differentiation. All affected in-
dividuals developed anemia, hyperkalemic metabolic ac-
idosis, and increased serum creatinine. The patients were
not initially hypertensive; however, hypertension devel-
oped concomitantly with the deterioration of renal func-
tion. All patients reached end-stage renal failure, ex-
cluding the youngest patient, who now has chronic renal
insufficiency, hypertension, and anemia. Progression
from disease onset to end-stage renal failure or death
due to renal complications was rapid (mean time, 7.8
mo; range, 3–18 mo). None of the affected subjects had
polyuria, polydypsia, or associated ocular or hepatic
complications.
The patients in this study showed most of the clinical
and histopathologic features reported by Gagnadoux et
al. (1989). Histopathologic examination of renal tissue
from four patients revealed cysts associated with
atrophic or undifferentiated tubules, with hyaline casts
in some of the lumens. The interstitium showed chronic
inflammation and fibrosis. Glomeruli were sclerotic or
had collapsed tufts. In the prenatally diagnosed case,
cystic formations of various sizes were evident, mainly
in the cortex, but also focally in the medullary areas.
Thickening of the tubular basement membrane was
rarely seen in the patients examined. Microcystic dila-
tations of tubules were present in the cortex.
Exclusion of Candidate Loci
Before performing a genomewide search for linkage
among the Bedouin family, we evaluated two loci where
diseases with overlapping phenotypes to NPH2 have
been mapped: the NPH1 locus on chromosome 2 (Med-
hiob et al. 1994) and the ARPKD locus on chromosome
6 (Guay-Woodford et al. 1995). The family was eval-
uated with STRPs both flanking and contained within
the candidate disease loci. Each locus was excluded at
LOD X2.0, indicating that NPH2 is not allelic with
either of these diseases.
Homozygosity Mapping
Once the candidate loci were excluded, a genomewide
screen to identify a locus for infantile nephronophthisis
was conducted. To efficiently identify the disease locus,
we genotyped each of the four affected individuals in
search of markers for which the affected individualswere
homozygous for the same allele. Two control DNApools
were also genotyped, to distinguish markers that were
homozygous by descent in the affected individuals from
those that were monomorphic in the kindred. These
pooled DNA samples consisted of a parental pool con-
taining DNA from parents of the affected individuals
and a sibling pool containing DNA from unaffected sib-
lings of the affected patients. This mapping strategy re-
lies on the assumption of identity by descent (IBD); that
is, affected individuals share a chromosomal region with
the same disease-causing mutation inherited from a com-
mon ancestor. The DNA samples were used as templates
for PCR amplification of STRPs developed by CHLC
(Sheffield et al. 1995). Three hundred STRPs, distributed
across the genome at ∼10-cM density, were used for the
initial screening. PCR products were electrophoresed on
a denaturing polyacrylamide gel and visualized by silver
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Table 2
Genotypes of Affected Individuals from the Infantile
Nephronophthisis Pedigree
AFFECTED INDIVIDUALS
MARKERS VII-1 VII- 3 VII- 17 VII-20
GATA11A07 1 1 2 1 1 1 1 1
D9S197 3 2 1 2 3 3 1 3
D9S280 2 3 4 3 2 2 3 2
D9S910 1 1 1 1 1 1 1 1
D9S277 1 1 1 1 1 1 1 1
D9S306 2 2 2 2 2 2 2 2
D9S938 1 1 1 1 1 1 1 1
GGAT3G09 3 3 3 3 3 1 3 3
D9S105 1 3 1 3 1 5 2 5
NOTE.—Recombination events in individuals VII-1, VII-3, and VII-
20 define the proximal flanking marker as D9S280. The distal flanking
marker is defined by individual VII-17 as GGAT3G09. The region
between the flanking markers is 12.9 cM, as defined by the Marshfield
chromosome 9 recombination map data (Center for Medical Genetics.
Note that all four affected individuals are homozygous for a shared
haplotype with markers D9S910, D9S277, D9S306, and D9S938.
Figure 2 Silver-stained gel of PCR products of DNA samples from the Bedouin kindred shown in figure 1. DNA from the affected
individuals (A), pooled DNA of parents (P), and pooled DNA of unaffected siblings (S) were used as a template to amplify STRPs in a genomewide
screen. The six lanes on the left depict results from an unlinked marker. All the affected individuals are heterozygous, and the pooled parental
and unaffected sibling samples show multiple alleles as well. The six lanes on the right depict results from a linked marker. All four affected
individuals are homozygous for the same allele, whereas the parental and unaffected sibling samples show multiple alleles, indicating that the
marker is informative in the kindred.
staining. STRPs for which all four affected individuals
were homozygous for the same allele, and for which the
parental and sibling pools showed multiple alleles, were
selected for further evaluation (fig. 2). Ten candidate
STRPs were identified for which at least three of the four
affected individuals were homozygous for the same al-
lele, and for which the unaffected pools showedmultiple
alleles. These loci were further evaluated by genotyping
markers flanking each of the candidate STRPs.
Genotyping of the four affected individuals with
markers flanking each of the 10 candidate STRPs re-
vealed a single region on chromosome 9 consistent with
linkage (table 2). All four affected individuals are ho-
mozygous for the same allele with markers D9S938 and
D9S910 (which lies 6 cM centromeric to D9S938). Three
of the four affected individuals are homozygous for cen-
tromeric flanking marker GATA11A07 and telomeric
flanking marker GGAT3G09. The other nine candidate
regions identified with markers from the genomewide
screen showed allele sharing with the primary marker
but not with flanking STRPs.
All available family members were individually gen-
otyped with markers from the chromosome 9 candidate
region, and linkage of infantile nephronophthisis to
markers on chromosome 9q22-31 was revealed (fig. 3).
The disease interval is defined by D9S280 as the prox-
imal flanking marker and GGAT3G09 as the distal
flanking marker. The distance between these markers is
estimated to be ∼12.9 cM on the basis of existing genetic
maps.
Statistical Analysis
We performed two-point LOD score analysis using
data generated by genotyping all 23 members of the
family with markers in the region flanked by
GATA11A07 and GGAT3G09 (table 3). A maximum
LOD score (Zmax) of 3.17 was obtained at recombination
fraction (v) of zero for marker D9S938. This marker is
informative in all matings, and all affected individuals
are homozygous for the disease allele.
Discussion
This study identifies a locus for infantile nephro-
nophthisis that further demonstrates the heterogeneous
nature of kidney disorders. The disease entity described
here is an uncommon cause of ESRD in infancy and
early childhood. The most common etiologies for ESRD
in infancy and early childhood are congenital structural
nephrourological anomalies, including dysplasia and ob-
structive uropathy (Qamar and Balfe 1991). The infants
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Figure 3 Genetic map of markers on the long arm of chromo-
some 9. Recombination distances are shown in centimorgans. This
map is based on the CHLC chromosome 9 recombination minimi-
zation map data. The disease interval is flanked by markers D9S280
and GGAT3G09.
in this study had a clinical picture of early-onset, rapidly
deteriorating kidney function, associated with metabolic
acidosis, anemia, and hypertension. It is unclear whether
the hyperkalemic metabolic acidosis described here is
part of the advanced renal insufficiency or is a result of
hyporeninemic hypoaldosteronism, as described in
chronic tubulointerstitial nephropathies (Schambelan et
al. 1980). The pathological picture of chronic tubuloin-
terstitial nephritis with cortical microcysts differs from
the one described in NPH1, in which cysts are identified
at the corticomedullary junction. In addition, there was
no liver involvement, which differentiates this entity
fromARPKD. This is the first report of a prenatal clinical
onset of nephronophthisis resulting in severe oligohy-
dramnion and postpartum death due to pulmonary hy-
poplasia. This manifestation may resemble ARPKD;
however, the association of severe tubulointerstitial ne-
phritis with nephronophthisis in other cases in this kin-
dred differs from the clinical findings seen in ARPKD.
The mapping of NPH2 to chromosome 9 in this study
demonstrates that NPH2 is not allelic to other renal
disorders such at ARPKD and NPH1.
The consanguineous nature of the Bedouin family
used in this study allowed the mapping of this disorder
by searching for homozygous regions of the genome
shared by the affected patients. An assumption of IBD
was made on the basis of pedigree information, the cul-
tural isolation of this population, and the rarity of the
disease in the general population. Individual DNA sam-
ples from affected individuals were used to identify
regions of homozygosity. Pooled DNA samples from the
parents and unaffected siblings were used to evaluate
the informativity of the markers in the kindred. This
study identified a locus for infantile nephronophthisis
on 9q22-q31. A significant LOD score of 3.17 with
marker D9S938 at v  0 supported linkage. Further
evidence of linkage was demonstrated by extensive allele
sharing among the affected individuals over a 12.9-cM
interval. The assumption of IBD at the disease locus was
confirmed by the fact that the affected individuals share
a common haplotype.
Identifying a disease locus is the first step toward iso-
lating the gene responsible for infantile nephronoph-
thisis. Because of the relatively large genetic interval de-
fined by the flanking markers, the identification of the
disease gene for this disorder will require the evaluation
of candidate genes. Candidate genes are considered on
the basis of their genetic location, expression pattern,
known function, and similarity to the NPH1 gene. A
database search indicates that there are ∼159 putative
transcripts in this interval. The Genebridge 4 panel (Wal-
ter et al. 1994) was used to generate a radiation hybrid
map of the NPH2 interval, with STRPs as a scaffold to
map candidate genes relative to the genetic interval.
Genes that map to this region include tropomodulin
(Sung et al. 1996) and a new member of the forkhead
family, FKHL15 (Chadwick et al. 1997). Tropomodulin
is involved in regulating tropomyosin and is expressed
in the kidney. FKHL15 is part of a family of eukaryot-
ic transcription factors (Grossniklaus et al. 1992).
FKHL15 contains the forkhead DNA–binding domain
as well as an alanine-rich region that is frequently as-
sociated with transcriptional repression. FKHL15 has a
wide tissue-expression pattern, including a 4.5-kb mes-
sage in the kidney.
Current morphological as well as molecular under-
standing of human polycystic kidney disease (PKD) has
been greatly aided by the existence of several animal
models (Schieren et al. 1996). Both by genetic manip-
ulation and through spontaneous mutations, severalmu-
rine models for PKD have been identified. The C57BL/
6J–cpk/cpk mouse model is the most extensively studied
murine model of inherited infantile PKD (Gattone et al.
1996; Martinez et al. 1997). These mice have a strictly
renal pathology. Using an outbred mouse background,
Gattone et al. (1996) showed strain-related variability
of renal and hepatic pathology and suggested that these
changes may reflect the influence of modifier genes ex-
pressed in a particular mouse strain. In a recent study,
QTL mapping identified two modifier loci of PKD pro-
gression (MOP 1 andMOP 2) in mice (Woo et al. 1997).
The MOP 1 locus maps to a region on mouse chro-
mosome 4 that is syntenic to human chromosome
9p22–9q32. MOP 1 alleles interact with MOP 2 alleles
to modulate the progression of PKD. The identification
of a PKD modifier locus in mice that is syntenic to the
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Table 3
Pairwise Linkage Data between Infantile Nephronophthisis and Markers on Chromosome 9
LOD SCORE AT vmax 
MARKER .0 .025 .05 .10 .20 .30 .40 v Zmax
GATA11A07  .634 .795 .829 .651 .451 .192 .75 .835
D9S910 2.72 2.50 2.29 1.86 1.099 .513 .152 .00 2.72
D9S938 3.169 2.94 2.71 2.27 1.43 .742 .260 .00 3.169
GGAT3G09  1.19 1.28 1.17 .745 .358 .104 .05 1.278
human NPH2 locus is interesting, and it suggests that
the NPH2 gene may play a role in modifying PKD in
humans.
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